TY  - JOUR
AU  - Capdevila, Jaume
AU  - Sevilla, Isabel
AU  - Alonso, Vicente
AU  - Antón Aparicio, Luís
AU  - Jiménez Fonseca, Paula
AU  - Grande, Enrique
AU  - Reina, Juan José
AU  - Manzano, José Luís
AU  - Alonso Lájara, Juan Domingo
AU  - Barriuso, Jorge
AU  - Castellano, Daniel
AU  - Medina, Javier
AU  - López, Carlos
AU  - Segura, Ángel
AU  - Carrera, Sergio
AU  - Crespo, Guillermo
AU  - Fuster, José
AU  - Munarriz, Javier
AU  - García Alfonso, Pilar
PY  - 2015
DO  - 10.1186/s12885-015-1512-6
UR  - http://hdl.handle.net/10668/1984
T2  - BMC cancer
AB  - BACKGROUNDBased on the mechanism of action, combining somatostatin analogues (SSAs) with mTOR inhibitors or antiangiogenic agents may provide synergistic effects for the treatment of patients with neuroendocrine tumours (NETs). Herein, we investigate...
LA  - en
PB  - BioMed Central
KW  - Lanreotide
KW  - Neuroendocrine tumours
KW  - Sunitinib
KW  - Everolimus
KW  - Somatostatin analogues
KW  - Clinical practice
KW  - Cross-sectional analysis
KW  - Combination treatment
KW  - Tumores Neuroendocrinos
KW  - Péptidos Cíclicos
KW  - Estudios Prospectivos
KW  - Sirolimus
KW  - Somatostatina
KW  - Inhibidores de la Angiogénesis
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Growth Substances::Angiogenesis Modulating Agents::Angiogenesis Inhibitors
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neuroendocrine Tumors
KW  - Medical Subject Headings::Check Tags::Male
KW  - Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Peptides, Cyclic
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal...
KW  - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Pyrroles
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Lactones::Macrolides::Sirolimus
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Pancreatic Neoplasms::Carcinoma, Islet Cell::Somatostatinoma
KW  - Medical Subject Headings::Geographicals::Geographic Locations::Europe::Spain
TI  - Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
TY  - research article
ER  -